📰 Risk Evaluation News
Page 43 - Risk Evaluation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Risk Evaluation. Real-time updates on events, politics, business and more.
February 25, 2023
The suit comes as a federal judge in another case is considering whether to overturn FDA approval of the same drug, mifepristone.
February 25, 2023
Attorneys General of Oregon and Washington have filed lawsuits with other states against the FDA's regulation of the abortion drug mifepristone.
February 25, 2023
Because mark is that right? >> there are these 12 blue states that have filed this lawsuit also against the fda and theyre seeking to remove the risk evaluation and mitigation strategies that apply to mifepristone, that apply to only a handful drugs, mifepristone being one of them. and the idea here is that it will make mifepristone more accessible to individuals, if those mitigation protocols are removed. but they have also asked for various legal remedies that would basically blunt anything th...
February 25, 2023
Attorneys General of Oregon and Washington have filed lawsuits with other states against the FDA's regulation of the abortion drug mifepristone.
February 25, 2023
Attorneys General of Oregon and Washington have filed lawsuits with other states against the FDA's regulation of the abortion drug mifepristone.
February 25, 2023
Attorneys General of Oregon and Washington have filed lawsuits with other states against the FDA's regulation of the abortion drug mifepristone.
February 25, 2023
FDA Faces Yet Another Lawsuit Over Abortion Pills — This Time From 12 Pro-Abortion States Micaela Burrow on February 24, 2023 Twelve blue states filed a
February 25, 2023
A group of a dozen state attorneys general, including Oregon Attorney General Ellen Rosenblum, is suing the Food and Drug Administration, alleging the federal agency is excessively regulating an abortion pill.
February 25, 2023
By Micaela Burrow Daily Caller News Foundation Twelve blue states filed a lawsuit Friday against the U.S. Food and Drug Administration (FDA) for placing “burdensome restrictions” on mifepristone, the first of two drugs used in a chemical abortion. WND is now on Trump's Truth Social! Follow us @WNDNews The lawsuit claims that current Risk Evaluation…
February 24, 2023
With approval of modified mifepristone Risk Evaluation and Mitigation Strategy REMS, it has been momentous time for reproductive health law. REMS are designed to reinforce medication use behaviors and actions that support the safe use of that medication.